Tokyo Tape
Sign in
← Em Systems

Quarterly report · Q2

4820.TEDINET S100OY0R
Period2022-01-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥14.4bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥6.7bn2021-01-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Operating income¥582m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.6bn2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.6bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥687m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss
Net income¥679m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥24.8bnat 2022-06-30Cons.Assets
Total assets¥24.8bnat 2021-12-31Cons.Assets
Total assets¥23.6bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-06-30Cons.Liabilities
Total liabilities¥6.0bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥18.8bnat 2021-12-31Cons.Net assets
Net assets / equity¥17.9bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥8.3bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥8.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥7.3bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.0bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.7bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥760m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥295m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥544m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥831m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥876m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥693m2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥400m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥15.352022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.422022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.722021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.682021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.312022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥25.642021-01-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥9.652021-01-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.4%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥55m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥184m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥347m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥328m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥19m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥22m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.5bn
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.3bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥4m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥16m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥356m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥351m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥5m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥11m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥1m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥591m
—segment totalrevenue2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue external2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue intersegment2021-01-01 → 2021-06-30¥6m
—segment totalsegment profit2021-01-01 → 2021-06-30¥567m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 537
ItemContextValueUnit
Income taxes payablePrior1YearInstant663000000JPY
Income taxes payableCurrentQuarterInstant596000000JPY
Provision for bonusesPrior1YearInstant403000000JPY
Provision for bonusesCurrentQuarterInstant292000000JPY
Provision for point card certificates clPrior1YearInstant4000000JPY
Provision for point card certificates clCurrentQuarterInstant－JPY
Contract liabilitiesPrior1YearInstant－JPY
Contract liabilitiesCurrentQuarterInstant1042000000JPY
Other clPrior1YearInstant1773000000JPY
Other clCurrentQuarterInstant580000000JPY
Current liabilitiesPrior1YearInstant4167000000JPY
Current liabilitiesCurrentQuarterInstant3788000000JPY
Lease obligations nclPrior1YearInstant1000000JPY
Lease obligations nclCurrentQuarterInstant74000000JPY
Net defined benefit liabilityPrior1YearInstant1039000000JPY
Net defined benefit liabilityCurrentQuarterInstant1072000000JPY
Provision for product warranties nclPrior1YearInstant50000000JPY
Provision for product warranties nclCurrentQuarterInstant24000000JPY
Long term guarantee depositedPrior1YearInstant724000000JPY
Long term guarantee depositedCurrentQuarterInstant739000000JPY
Noncurrent liabilitiesPrior1YearInstant1815000000JPY
Noncurrent liabilitiesCurrentQuarterInstant1910000000JPY
LiabilitiesPrior1YearInstant5983000000JPY
LiabilitiesCurrentQuarterInstant5699000000JPY
Capital stockPrior1YearInstant2785000000JPY
Capital stockCurrentQuarterInstant2785000000JPY
Capital surplusPrior1YearInstant3347000000JPY
Capital surplusCurrentQuarterInstant3347000000JPY
Retained earningsPrior1YearInstant14116000000JPY
Retained earningsCurrentQuarterInstant14678000000JPY
Treasury stockPrior1YearInstant-1539000000JPY
Treasury stockCurrentQuarterInstant-1883000000JPY
Shareholders equityPrior1YearInstant18708000000JPY
Shareholders equityCurrentQuarterInstant18926000000JPY
Foreign currency translation adjustmentPrior1YearInstant69000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant115000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-49000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-42000000JPY
Valuation and translation adjustmentsPrior1YearInstant19000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant72000000JPY
Subscription rights to sharesPrior1YearInstant55000000JPY
Subscription rights to sharesCurrentQuarterInstant55000000JPY
Non controlling interestsPrior1YearInstant42000000JPY
Non controlling interestsCurrentQuarterInstant33000000JPY
Net assetsPrior1YearInstant18826000000JPY
Net assetsCurrentQuarterInstant19088000000JPY
Liabilities and net assetsPrior1YearInstant24809000000JPY
Liabilities and net assetsCurrentQuarterInstant24787000000JPY
Net salesPrior1YTDDuration6672000000JPY
Net salesCurrentYTDDuration8164000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass